Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 30;192(48):E1620-E1632.
doi: 10.1503/cmaj.202353. Epub 2020 Nov 3.

Key populations for early COVID-19 immunization: preliminary guidance for policy

Shainoor J Ismail  1 , Linlu Zhao  1 , Matthew C Tunis  1 , Shelley L Deeks  1 , Caroline Quach  1 ; National Advisory Committee on Immunization
Affiliations

Key populations for early COVID-19 immunization: preliminary guidance for policy

Shainoor J Ismail et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Members of the National Advisory Committee on Immunization (NACI) are recognized experts who volunteer their time and are not remunerated for their contributions to NACI guidance. All authors declare that they have no known competing financial interests or personal relationships that could have, or could appear to have, influenced the work reported in this paper. Shainoor Ismail, Linlu Zhao and Matthew Tunis are employees of the Public Health Agency of Canada. Shelley Deeks is an employee of Public Health Ontario. Shelley Deeks and Caroline Quach have both received grants to conduct research on immunization issues unrelated to SARS-CoV-2 vaccines. No other competing interests were declared.

Figures

Figure 1:
Figure 1:
Summary of preliminary National Advisory Committee on Immunization (NACI) recommendations on key populations for early coronavirus disease 2019 (COVID-19) immunization. Note: *Order does not indicate priority. †Based on the systematic assessment of ethics, equity, feasibility and acceptability using an evidence-informed framework.
See this image and copyright information in PMC

References

    1. Coronavirus disease 2019 (COVID-19): situation report – 51. Geneva: World Health Organization; 2020. Mar. 11 Available: www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-... (accessed 2020 July 11).
    1. Coronavirus disease (COVID-19): outbreak update. Ottawa: Government of Canada; modified 2020 Sept. 13. Available: www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-... (accessed 2020 Oct. 15).
    1. Federal/provincial/territorial public health response plan for ongoing management of COVID-19. Ottawa: Government of Canada; modified 2020 Aug. 25. Available: www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-... (accessed 2020 Aug. 26).
    1. Coronavirus disease (COVID-19): for health professionals. Ottawa: Government of Canada; modified 2020 Oct. 10. Available: www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-... (accessed 2020 Sept. 24).
    1. Benefits of immunization: Canadian immunization guide. Ottawa: Government of Canada; 2016. Available: www.canada.ca/en/public-health/services/publications/healthy-living/cana... (accessed 2020 June 21).

MeSH terms

Substances